{"id":"https://openalex.org/W4310108136","doi":"https://doi.org/10.1182/blood-2022-168859","title":"Zanubrutinib PLUS RCHOP(ZR-CHOP) Regimen Achieves High Complete Response Rate in the Treatment of Newly-Diagnosed Double-Expression Diffuse Large B Cell Lymphoma","display_name":"Zanubrutinib PLUS RCHOP(ZR-CHOP) Regimen Achieves High Complete Response Rate in the Treatment of Newly-Diagnosed Double-Expression Diffuse Large B Cell Lymphoma","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310108136","doi":"https://doi.org/10.1182/blood-2022-168859"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-168859","doi":"https://doi.org/10.1182/blood-2022-168859","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-168859","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114108310","display_name":"Qiang He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiang He","raw_affiliation_strings":["1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043807045","display_name":"Linna Xie","orcid":"https://orcid.org/0000-0001-7542-7402","observed_orcids":["https://orcid.org/0000-0001-7542-7402"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Linna Xie","raw_affiliation_strings":["1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013656345","display_name":"Rongrong Zhao","orcid":"https://orcid.org/0000-0001-5626-1961","observed_orcids":["https://orcid.org/0000-0001-5626-1961"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rongrong Zhao","raw_affiliation_strings":["1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060446712","display_name":"Ji Ma","orcid":"https://orcid.org/0000-0001-5724-1743","observed_orcids":["https://orcid.org/0000-0001-5724-1743"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ji Ma","raw_affiliation_strings":["1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100460769","display_name":"Hui Wang","orcid":"https://orcid.org/0000-0002-3470-4159","observed_orcids":["https://orcid.org/0000-0002-3470-4159","https://orcid.org/0000-0001-8033-5924"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hui Wang","raw_affiliation_strings":["1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100428160","display_name":"Jie Li","orcid":"https://orcid.org/0000-0001-6165-2668","observed_orcids":["https://orcid.org/0000-0001-6165-2668"]},"institutions":[{"id":"https://openalex.org/I4210161528","display_name":"Qilu Hospital of Shandong University","ror":"https://ror.org/056ef9489","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210161528"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Li","raw_affiliation_strings":["2Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China","institution_ids":["https://openalex.org/I4210161528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101896558","display_name":"Chuanli Zhao","orcid":"https://orcid.org/0000-0003-4511-8566","observed_orcids":["https://orcid.org/0000-0003-4511-8566"]},"institutions":[{"id":"https://openalex.org/I154099455","display_name":"Shandong University","ror":"https://ror.org/0207yh398","country_code":"CN","type":"education","lineage":["https://openalex.org/I154099455"]},{"id":"https://openalex.org/I4210161528","display_name":"Qilu Hospital of Shandong University","ror":"https://ror.org/056ef9489","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210161528"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chuanli Zhao","raw_affiliation_strings":["3Qilu Hospital of Shandong University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Qilu Hospital of Shandong University, Jinan, China","institution_ids":["https://openalex.org/I154099455","https://openalex.org/I4210161528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062344658","display_name":"Y. Lynn Wang","orcid":"https://orcid.org/0000-0003-0773-1212","observed_orcids":["https://orcid.org/0000-0003-0773-1212"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Lynn Wang","raw_affiliation_strings":["4Department of Pathology, Fox Chase Cancer Center, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Pathology, Fox Chase Cancer Center, Wilmington, DE","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000632526","display_name":"Zengjun Li","orcid":"https://orcid.org/0000-0003-0787-8089","observed_orcids":["https://orcid.org/0000-0003-0787-8089"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zengjun Li","raw_affiliation_strings":["1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.6732,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.66945918,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"6614","last_page":"6615"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zanubrutinib","display_name":"zanubrutinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.8999999761581421},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6269999742507935},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.6570000052452087},{"id":"https://openalex.org/keywords/complete-response-rate","display_name":"complete response rate","score":0.7509999871253967},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9850000143051147},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6230000257492065},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.48100000619888306},{"id":"https://openalex.org/keywords/pet-ct-response-assessment","display_name":"PET/CT response assessment","score":0.5929999947547913},{"id":"https://openalex.org/keywords/relapse-after-autologous-stem-cell-transplantation","display_name":"relapse after autologous stem cell transplantation","score":0.5899999737739563},{"id":"https://openalex.org/keywords/relapse-after-allogeneic-stem-cell-transplantation","display_name":"relapse after allogeneic stem cell transplantation","score":0.8679999709129333}],"concepts":[{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.7338932752609253},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6393975019454956},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.620962381362915},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5766779184341431},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.5356615781784058},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.5340729355812073},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5149043798446655},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4898921847343445},{"id":"https://openalex.org/C2778476033","wikidata":"https://www.wikidata.org/wiki/Q1667625","display_name":"International Prognostic Index","level":4,"score":0.4300982654094696},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4082055687904358},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.270049512386322},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.11254265904426575},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.07597458362579346}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-168859","doi":"https://doi.org/10.1182/blood-2022-168859","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-168859","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4283369811","https://openalex.org/W4405051100","https://openalex.org/W4408379233","https://openalex.org/W4417014988","https://openalex.org/W4310162514","https://openalex.org/W4389258240","https://openalex.org/W4411330586","https://openalex.org/W3216724399","https://openalex.org/W4405047575","https://openalex.org/W7108457141"],"abstract_inverted_index":{"Background:":[0],"Diffuse":[1],"large":[2],"B":[3],"cell":[4,456],"lymphoma":[5],"with":[6,28,117,155,207,253],"double":[7,173],"expression":[8,551],"of":[9,18,26,95,113,123,139,198,227,237,258,268,274,279,290,307,330,367,377,391,441,468,490,500,532],"myc/BCL2(DE-DLBCL),":[10],"is":[11,30,158,400,408],"usually":[12],"responsive":[13],"poorly":[14],"to":[15,68,247,323,345,528,536],"standard":[16,195],"therapy":[17,238,453],"R-CHOP":[19,41,89,142,382,537],"regimen,":[20],"And":[21,262],"the":[22,58,69,93,104,120,213,280,378,394,403,418,442,466,469,501,520,530,554],"long-term":[23],"survival":[24],"rate":[25,163,363,396,405,515],"patients":[27,186,252,264,270,281,293,412,422,444,449],"DE-DLBCL":[29,51,96,124,157,385],"only":[31],"30%":[32],"-":[33],"40%.":[34],"Recently,":[35],"Phoenix":[36],"study":[37,525],"demonstrate":[38],"Ibrutinib":[39,73],"plus":[40,48,88,141,200],"improved":[42],"EFS":[43],"and":[44,111,166,172,183,220,300,319,348,436,505,519,548],"OS":[45],"(versus":[46],"placebo":[47],"R-CHOP)":[49],"for":[50,55,119,153,164,168,225,239,384,516,538,557],"younger":[52],"patients.":[53,100,125],"While":[54],"elder":[56],"patients,":[57],"outcome":[59,94],"makes":[60],"no":[61,208],"difference":[62],"between":[63],"two":[64],"groups,":[65],"due":[66,322,344],"partly":[67],"poor":[70],"tolerance":[71],"in":[72,98,147,187,284,495],"group.":[74],"The":[75,185,194,276,361,483],"novel":[76],"BTK":[77],"inhibitor,":[78],"zanubrutinib,":[79],"have":[80],"better":[81],"safety":[82,112,467],"profile.":[83],"So":[84],"we":[85],"suppose":[86],"zanubrutinib":[87,118,533],"(ZR-CHOP)":[90,144],"may":[91],"improve":[92],"even":[97],"older":[99],"Objective:":[101],"To":[102],"investigate":[103],"response":[105,362],"rate,":[106],"PFS":[107,395,404],"(progression":[108],"free":[109],"survival)":[110],"RCHOP":[114],"regimen":[115,143,371,383,510],"combined":[116],"first-line":[121,151],"treatment":[122,152],"Method:":[126],"We":[127],"initiate":[128],"a":[129],"prospective,":[130],"single":[131],"arm,":[132],"phase":[133],"II":[134],"clinical":[135],"trial.":[136],"Standard":[137],"dose":[138],"Zanubrutinib":[140],"was":[145,212,232,372],"adopted":[146],"our":[148],"center":[149],"as":[150,160,204],"patients(18-75yrs)":[154],"DE-DLBCL.":[156,540],"defined":[159],"\u226740%":[161],"positive":[162],"myc":[165],"\u226750%":[167],"bcl2":[169,182],"by":[170],"immunohistochemistry,":[171],"hit":[174],"cases":[175],"were":[176,192,202,223,256,460,477,493,522,552],"excluded":[177],"through":[178],"FISH":[179],"test":[180],"(myc,":[181],"bcl6).":[184],"Ann":[188],"Arbor":[189],"stage":[190],"I":[191],"excluded.":[193],"6":[196,221,272,328,365,398],"-8cycles":[197],"ZR-CHOP":[199],"2R":[201],"administered":[203],"induction":[205,419],"therapy,":[206,291,308,331],"maintenance":[209],"therapy.":[210,420,464],"Two-year-PFS":[211],"primary":[214,240],"endpoint.":[215],"PET-CT":[216],"after":[217,234,359,364,381,417,450,462],"4":[218,266,305],"cycles":[219,222,236,267,273,289,306,329,366],"used":[224,233],"assessment":[226],"response,":[228],"but":[229],"CT":[230],"scanning":[231],"2":[235,288],"assessment.":[241],"Results:":[242],"From":[243],"November":[244],"6,":[245],"2020":[246],"July":[248],"20,":[249],"2022,":[250],"46":[251],"DE":[254,517],"DLBCL":[255],"enrolled\uff0ctwo":[257],"them":[259],"voluntarily":[260],"quit.":[261],"44":[263],"completed":[265,271],"chemotherapy,36":[269],"chemotherapy.":[275,360],"baseline":[277],"characteristics":[278],"are":[282,445,479,526],"listed":[283],"Table":[285],"1.":[286],"After":[287,304,327,388],"5/44":[292],"achieved":[294,511],"CR":[295,311,333,514],"(11.36%),":[296],"36/44":[297,309],"PR":[298,314,336],"(81.82%)":[299],"3/44":[301,339],"not":[302,350],"evaluated\uff086.82%\uff09.":[303],"got":[310],"(81.82%),":[312],"6/44":[313],"(13.64%)":[315],",1/44":[316],"PD":[317,340],"(2.27%),":[318],"1/34":[320],"died":[321,343,461],"cardiovascular":[324,346,488],"events":[325],"(2.27%).":[326],"30/44":[332],"(68.18%),":[334],"1/44":[335,342],"(2.27%)":[337],",":[338,543],"(6.82%),and":[341],"events(2.27%)":[347],"9/44":[349],"evaluated\uff0820.45%\uff09(Figure":[351],"1).In":[352],"addition,":[353],"one":[354,458],"patient":[355,459],"relapsed":[356],"3":[357,472],"months":[358],"ZRCHOP":[368,509],"(36":[369],"patients)":[370],"obviously":[373],"higher":[374],"than":[375,482],"that":[376],"previous":[379],"report":[380],"(86.11%VS":[386],"70%).":[387],"median":[389],"follow-up":[390,507],"9":[392],"month(2-20m),":[393],"at":[397,406],"month":[399],"97.4%\uff08CI":[401],"94.8-100\uff09,":[402],"12month":[407],"85%\uff08CI":[409],"77.8-92.2\uff09.Totally":[410],"five":[411,443],"progressed":[413],"during":[414],"or":[415,473],"shortly":[416],"Five":[421],"had":[423],"molecular":[424],"genetic":[425],"high-risk":[426],"factors,":[427],"including":[428,454],"TP53":[429,541],"mutation,":[430,432],"ATM":[431,544],"P53":[433],"protein":[434,438,546,550],"expression,":[435,547],"CD5":[437,549],"expression.":[439],"Among":[440],"still":[446],"alive":[447],"four":[448],"second":[451],"line":[452],"auto-stem":[455],"transplantation,":[457],"CAR-T":[463],"About":[465],"study,":[470],"grade":[471],"more":[474],"severe":[475],"AEs":[476],"recorded":[478],"slightly":[480],"less":[481],"PHOENIX":[484],"study.":[485,497],"No":[486],"adverse":[487],"reactions":[489],"any":[491],"level":[492],"found":[494],"this":[496],"Conclusions:":[498],"Despite":[499],"small":[502],"sample":[503],"size":[504],"short":[506],"time,":[508],"very":[512],"high":[513],"DLBCL,":[518],"toxicities":[521],"acceptable.":[523],"Further":[524],"required":[527],"prove":[529],"benefit":[531],"when":[534],"added":[535],"newly-diagnosed":[539],"mutation":[542],"mutation,P53":[545],"probably":[553],"main":[555],"reason":[556],"disease":[558],"progression.":[559],"Figure":[560],"1View":[561,564],"largeDownload":[562,565],"PPTFigure":[563],"PPT":[566],"Close":[567],"modal":[568]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-30T00:00:00"}